OmniAb Inc

OABI | News | $4.64 -0.86% -0.86% 370K

(0.0% 1d) (-12.6% 1m) (33.3% 1y) (0.0% 2d) (-0.9% 3d) (-0.6% 7d) (22.14% volume)
Earnings Calendar: 2023-11-09
Market Cap: $ 544,791,880

Sec Filling | Patents | 2021 employees

the omniab discovery platform provides pharmaceutical industry partners access to diverse antibody repertoires and high-throughput screening technologies to enable discovery of next-generation therapeutics.

add to watch list Paper trade email alert is off

Press-releases

OmniAb to Report First Quarter 2024 Financial Results on May 9
Published: 2024-04-22 (Crawled : 13:00) - biospace.com/
OABI | News | $4.64 -0.86% -0.86% 370K

| -0.64% | O: 0.0% H: 1.93% C: 0.21%
first report financial results

Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody Drug Conjugate (ADC) Biotherapeutics
Published: 2024-04-15 (Crawled : 13:00) - biospace.com/
OABI | News | $4.64 -0.86% -0.86% 370K

| -8.12% | O: -1.58% H: 1.77% C: -0.4%
drug liver disease antibody for

OmniAb Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
Published: 2024-03-20 (Crawled : 00:00) - biospace.com/
OABI | News | $4.64 -0.86% -0.86% 370K

| -11.95% | O: -0.76% H: 4.02% C: 3.63%
JNJ | News | $149.56 0.3% 0.0% 9.1M

Health Technology

| -4.5% | O: -0.65% H: 0.0% C: 0.0%
business year financial results

OmniAb to Report Fourth Quarter 2023 Financial Results on March 20
Published: 2024-02-26 (Crawled : 15:30) - biospace.com/
OABI | News | $4.64 -0.86% -0.86% 370K

| -15.48% | O: 0.0% H: 4.55% C: 4.37%
report financial results

OmniAb to Participate in Two Investor Conferences in March
Published: 2024-02-20 (Crawled : 14:00) - biospace.com/
OABI | News | $4.64 -0.86% -0.86% 370K

| -17.73% | O: -0.71% H: 1.79% C: -1.07%

OmniAb Reports Third Quarter 2023 Financial Results and Business Highlights
Published: 2023-11-09 (Crawled : 14:30) - biospace.com/
OABI | News | $4.64 -0.86% -0.86% 370K

| 1.98% | O: -2.2% H: 2.81% C: -2.02%
LGND | $69.97 2.1% 2.06% 140K

Health Technology

| 33.81% | O: 5.28% H: 0.93% C: -0.64%
business financial results

OmniAb to Hold Research & Technology Virtual Event on November 9
Published: 2023-10-12 (Crawled : 13:00) - biospace.com/
OABI | News | $4.64 -0.86% -0.86% 370K

| -8.66% | O: -0.2% H: 0.0% C: -2.56%
research technology

OmniAb Reports Second Quarter 2023 Financial Results and Business Highlights
Published: 2023-08-10 (Crawled : 23:00) - biospace.com/
OABI | News | $4.64 -0.86% -0.86% 370K

| -19.86% | O: 1.38% H: 0.0% C: -1.53%
LGND | $69.97 2.1% 2.06% 140K

Health Technology

| -1.17% | O: 0.18% H: 0.04% C: -2.99%
business financial results

OmniAb to Report Second Quarter 2023 Financial Results on August 10
Published: 2023-07-31 (Crawled : 13:00) - biospace.com/
OABI | News | $4.64 -0.86% -0.86% 370K

| -13.43% | O: 0.0% H: 2.8% C: 2.61%
report financial results

OmniAb Launches OmniDeep™ at the PEGS Boston Conference and Expo
Published: 2023-05-17 (Crawled : 22:00) - biospace.com/
OABI | News | $4.64 -0.86% -0.86% 370K